Array BioPharma, Inc. To Report Financial Results For The Third Quarter Of Fiscal 2014 On April 29, 2014
BOULDER, Colo., April 23, 2014 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2014 and hold a conference call to discuss those results on Tuesday, April 29, 2014. Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call.
Conference Call Information | |
Date: | Tuesday, April 29, 2014 |
Time: | 9:00 a.m. eastern time |
Toll-Free: | (800) 708-4540 |
Toll: | (847) 619-6397 |
Pass Code: | 36946658 |
Webcast, including Replay and Conference Call Slides: | |
http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-irhome | |
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Seven Phase 3 or pivotal studies are already in progress, or are planned to begin, within the next year. These programs include the wholly-owned hematology drug, filanesib for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (Novartis). For more information on Array, please go to www.arraybiopharma.com
CONTACT: | Tricia Haugeto |
Array BioPharma Inc. | |
(303) 386-1193 | |
Logo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO
SOURCE Array BioPharma Inc.
Help employers find you! Check out all the jobs and post your resume.